Digital Regulators open the AI floodgates in life sciences In 2026, biopharma will move from proving AI works to proving it can be trusted at scale.
Digital Garbage in, garbage out: The hidden data crisis in pharma This hidden data crisis is the fundamental barrier to scaling AI in the life sciences sector.
Digital How integrated patient experience platforms are revolutionis... AI-powered integrated platforms offer an elemental shift in the way that clinical trials are conducted.
Digital Harnessing AI to make Medicare more efficient, fair, and pat... As part of “WISeR” requirements, CMS selected tech vendors to implement enhanced technological models to scrutinise claims involving those on Medicare
Digital Digital transformation as a third lever in the affordability... Alfred Olivares, global managing partner, healthcare & medtech, at HTEC, discusses how AI and tech can help address the affordability challenge.
Digital From brand sites to unified portals: Why pharma is consolida... Global HCP platforms are emerging as the new standard, offering a single place where professionals can find information, tools, and support.
Patients Biosimilars & patient access independent of geographies or s... Rebecca Guntern, Sandoz' CCO, discusses the ‘golden decade’ for generics and biosimilars as so many blockbuster drugs come off patent.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
